Boston Healthcare
Global strategy consulting firm advising healthcare innovators on demonstrating and capturing clinical and economic value. Services emphasize health economics, market access, evidence development, product and portfolio strategy, and M&A support for medical device, diagnostics, biopharmaceutical, and digital health companies.
Industries
Nr. of Employees
small (1-50)
Boston Healthcare
Boston, Massachusetts, United States, North America
Products
Health Economic
Analytical consulting to evaluate the health economics and reimbursement potential of high-value specialty, orphan, and precision drugs.
Health Economic Modeling
Development of economic models to demonstrate cost-effectiveness and economic impact.
Pricing, Reimbursement, and Market Access Consulting
Strategic consulting services to navigate complex policy and payment environments, helping life sciences clients align product value with reimbursement and funding stakeholder expectations.
Innovation and Product Development Consulting
Consulting services focused on delivering innovation in a value-based healthcare environment through evidence-based value assessment, portfolio prioritization, and product development market access evaluation.
Advanced Diagnostics Healthcare Consulting
Strategic consulting services supporting innovation in advanced diagnostics and laboratory services by developing go-to-market, market access, reimbursement, and value communication strategies.
Commercial Due Diligence
Commercial due diligence services evaluating transaction opportunities, evidence gaps, and reimbursement challenges.
Health Economic
Analytical consulting to evaluate the health economics and reimbursement potential of high-value specialty, orphan, and precision drugs.
Health Economic Modeling
Development of economic models to demonstrate cost-effectiveness and economic impact.
Pricing, Reimbursement, and Market Access Consulting
Strategic consulting services to navigate complex policy and payment environments, helping life sciences clients align product value with reimbursement and funding stakeholder expectations.
Innovation and Product Development Consulting
Consulting services focused on delivering innovation in a value-based healthcare environment through evidence-based value assessment, portfolio prioritization, and product development market access evaluation.
Advanced Diagnostics Healthcare Consulting
Strategic consulting services supporting innovation in advanced diagnostics and laboratory services by developing go-to-market, market access, reimbursement, and value communication strategies.
Commercial Due Diligence
Commercial due diligence services evaluating transaction opportunities, evidence gaps, and reimbursement challenges.
Services
Develop models, burden-of-illness analyses, value dossiers, and payer-facing communication to support coverage and reimbursement.
Assess payer landscapes, coding, pricing, and create reimbursement roadmaps with implementation support.
Market opportunity assessments, pricing strategy, go-to-market planning, and revenue forecasting informed by health economic inputs.
Evidence-driven portfolio prioritization and evaluation of product development processes to optimize value creation.
Commercial due diligence and market/M&A landscape analysis with focus on evidence and market access risks.
Develop models, burden-of-illness analyses, value dossiers, and payer-facing communication to support coverage and reimbursement.
Assess payer landscapes, coding, pricing, and create reimbursement roadmaps with implementation support.
Market opportunity assessments, pricing strategy, go-to-market planning, and revenue forecasting informed by health economic inputs.
Evidence-driven portfolio prioritization and evaluation of product development processes to optimize value creation.
Commercial due diligence and market/M&A landscape analysis with focus on evidence and market access risks.
Expertise Areas
- Health economic analysis and modeling
- Market access and reimbursement strategy
- Market opportunity assessment and forecasting
- Evidence development and publication strategy
Key Technologies
- Next-generation sequencing (NGS)
- Polymerase chain reaction (PCR)
- Mass spectrometry
- Immunoassay platforms
News & Updates
Announcement that the firm will be part of a new company called Veranex.
Article summarizing timelines and considerations for registering medical devices and IVDs in China for investors and commercial teams.
Overview of policy changes accelerating digital health adoption in Germany and implications for coverage of digital health applications.
Summary of key takeaways from the NCCN 2021 Annual Conference including guideline updates and equity topics.
Presented conjoint analysis results estimating primary care physician preferences for kidney disease testing; supported health economic value demonstration for a kidney diagnostic.
Presentation of health economic findings for an AI-enabled IVD identifying CKD patients at risk of rapid decline during a late-breaker session at the National Kidney Foundation meeting.
Announcement that the firm will be part of a new company called Veranex.
Article summarizing timelines and considerations for registering medical devices and IVDs in China for investors and commercial teams.
Overview of policy changes accelerating digital health adoption in Germany and implications for coverage of digital health applications.
Summary of key takeaways from the NCCN 2021 Annual Conference including guideline updates and equity topics.
Presented conjoint analysis results estimating primary care physician preferences for kidney disease testing; supported health economic value demonstration for a kidney diagnostic.
Presentation of health economic findings for an AI-enabled IVD identifying CKD patients at risk of rapid decline during a late-breaker session at the National Kidney Foundation meeting.